BlackRock Fund Advisors - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$28,000
-30.0%
58,972
+2.8%
0.00%
Q3 2016$40,000
-54.5%
57,350
+29.9%
0.00%
Q2 2016$88,000
-18.5%
44,140
-1.7%
0.00%
Q1 2016$108,000
-70.9%
44,904
-7.2%
0.00%
Q4 2015$371,000
+51.4%
48,368
+4.6%
0.00%
Q3 2015$245,000
-35.2%
46,263
+9.7%
0.00%
Q2 2015$378,000
+34.0%
42,167
-5.5%
0.00%
Q1 2015$282,000
+67.9%
44,598
+54.7%
0.00%
Q4 2014$168,000
-8.2%
28,825
+7.7%
0.00%
Q3 2014$183,000
-51.1%
26,773
+2.7%
0.00%
Q2 2014$374,00026,0700.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders